Ruxolitinib in Children with Steroid Refractory Acute Graft Versus Host Disease: A Multicenter Study of the Pediatric Group of SFGM-TC

L. Laisne (1) , B. Neven , J. H. Dalle , C. Galambrun (2) , M. Esvan (3) , C. Renard (4) , F. Rialland (5) , A. Sirvent (6) , V. Gandemer (1)

1 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
2 CHU Marseille
3 CIC - Centre d'Investigation Clinique [Rennes]
4 Hôpital Edouard Herriot [CHU - HCL]
5 CHU Nantes - Centre Hospitalier Universitaire de Nantes
6 CHU - Hôpital Lapeyronie [Montpellier]

Domaines: Sciences du Vivant [q-bio]

L. Laisne, B. Neven, J. H. Dalle, C. Galambrun, M. Esvan, et al.. Ruxolitinib in Children with Steroid Refractory Acute Graft Versus Host Disease: A Multicenter Study of the Pediatric Group of SFGM-TC. Pediatric Blood and Cancer, 2019, 66, pp.S43-S44. ⟨hal-02355531⟩